Blog & News

Pharma Insights

Industry updates, product launches, business guides, and scientific articles from the Grapheal Pharmaceuticals team.

Home/Blog & News
🏭
Facilities & Quality
Grapheal Expands Product Portfolio with New Certified Range
Our supply network is expanding with a new range of high-quality certified products added to our portfolio, ensuring reliable healthcare access.
GP
Grapheal Pharma
Mar 5, 2026
🔬
R&D
Sustained-Release Formulations: Next-Gen Drug Delivery in Focus
Our R&D team shares insights on the development of sustained-release Metformin tabs that improve patient compliance in Type 2 diabetes management.
PM
Dr. Priya Mehta
Feb 20, 2026
💹
Business
Complete Guide to PTR & PTS Calculation for Pharma Products
A step-by-step breakdown of how to calculate Price To Retailer (PTR) and Price To Stockist (PTS) with GST adjustments — explained with examples.
AS
Anand Shah
Feb 10, 2026
📋
Regulatory
New D&C Amendment Rules 2025: What Pharma Providers Need to Know
A summary of the latest Drugs and Cosmetics Act amendments and how Grapheal Pharmaceuticals is proactively ensuring full compliance.
SJ
Sunita Joshi
Jan 28, 2026
🏥
Industry News
India's Pharmaceutical Industry to Cross $130 Billion by 2030
An analysis of India's pharma sector growth trajectory, government initiatives, and how domestic suppliers like Grapheal are poised for expansion.
GP
Grapheal Pharma
Jan 15, 2026
👶
R&D
Developing Paediatric-Friendly Medicines: Challenges & Solutions
Formulating medicines that children actually take — our research on dispersible tablets, mini-tablets, and flavored suspensions for paediatric patients.
PM
Dr. Priya Mehta
Jan 5, 2026